Gene · 79679
NIH grants878
NIH grants whose papers are about the gene, through NIH's grant-paper links.
81 to 100 of 878
Download this page as JSON| Grant | Title | VTCN1 papers | Newest fiscal year |
|---|---|---|---|
| R01AI125524 | Kinase Regulation of Nuclear Speckle Function and Splicing during Influenza Virus Infection | 1 | 2025 |
| R01AI144422 | Structure, Function and Mechanistic Analysis of LAG3 | 1 | 2025 |
| R01CA143130 | Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal | 1 | 2025 |
| R01CA148761 | Therapeutic Targeting of Breast Cancer Tumor Initiating Cells | 1 | 2025 |
| R01CA197916 | Targeting the liver for immunotherapy in pancreatic cancer | 1 | 2025 |
| R01CA204302 | Characterization of YAP as a rational companion target in lung cancer | 1 | 2025 |
| R01CA226909 | Therapeutic Targeting of Macrophage PI3Kgamma in HNSCC | 1 | 2025 |
| R01CA236356 | Protein arginine methylation in breast cancer | 1 | 2025 |
| R01CA254988 | Effective combination therapy for MTAP-deficient bladder carcinoma by targeting metabolic vulnerability and modulating tumor immune microenvironment | 1 | 2025 |
| R01CA258765 | Targeting posttranslational modifications of B7-H4 in carcinogenesis and therapy | 1 | 2025 |
| R01CA258857 | Targeting posttranslational modifications of CD73 in TNBCs | 1 | 2025 |
| R01CA260628 | Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women | 1 | 2025 |
| R01CA260858 | Regulation of tumor-infiltrating T cells by macrophages | 1 | 2025 |
| R01CA261985 | CTL-killing capacity and cancer stiffness in cancer immunity and therapy | 1 | 2025 |
| R01CA262132 | A New Immune Checkpoint Pathway in Human Bladder Cancer | 1 | 2025 |
| R01CA262377 | Understanding the role and clinical potential of dominant immune suppressive myeloid-cell responses in human cancer | 1 | 2025 |
| R01CA284315 | Dual targeting of PI3K and NOS pathways in Metaplastic BreastCancer (MBC) | 1 | 2025 |
| R01DC017461 | Engineering multi-lineage inner ear organoids | 1 | 2025 |
| R01DK095735 | B-lymphocyte Targeting Therapies for Autoimmune Diabetes | 1 | 2025 |
| R01GM102491 | The Discovery of Human Peptide Encoding Genes | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/grants?page=5